Atrial fibrillation epidemic and hospitalizations: how to turn the rising tide?

Numerous countries worldwide are facing the major challenge of rising healthcare expenditure, a concern driven particularly by advancing medical treatments and aging population structures. In the United States over the past 50 years, increasing national healthcare expenditure has consistently outpaced growth in real gross domestic product per capita, exceeding every other country to peak at 18% of the gross domestic product in 2012.1 Given that hospitals are the largest contributor to each dollar spent on health care, the characterization of hospitalization trends is a logical first step in identifying possible opportunities to intervene and slow the rising demands on healthcare systems. Article see p 2371 It is in this context that Patel and colleagues describe contemporary trends of hospitalizations for atrial fibrillation (AF) in the current issue of Circulation .2 An increasing number of recent studies have highlighted the emergence of AF as a growing epidemic.3,4 Although the morbidity and mortality associated with this most common arrhythmia has been increasingly well characterized, few studies have comprehensively described the effect of rising AF rates on hospital use on a national scale. Using data from the Nationwide Inpatient Sample, Patel and colleagues therefore characterized the trend of hospitalization rates for AF in the United States from 2000 to 2010. They found an overall 23% growth in AF hospitalizations, importantly noting that the increase was particularly prominent in elderly patients. More than two-thirds of the patients were >65 years of age, and those >80 years of age had an exponential increase in hospitalization rates (9361 per million in 2001 to 11 045 per million in 2010). Furthermore, despite a static mean length of stay and declining in-hospital mortality associated with AF hospitalizations, inflation-adjusted costs from these hospitalizations rose from $6410 in 2001 to $8439 in 2010. As a …

[1]  J. Kluger,et al.  Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models , 2013, PloS one.

[2]  W. Abhayaratna,et al.  Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. , 2013, JAMA.

[3]  Simon Stewart,et al.  Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. , 2013, International journal of cardiology.

[4]  P. Alboni,et al.  Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. , 2004, The New England journal of medicine.

[5]  M. Ezekowitz,et al.  Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. , 2013, American heart journal.

[6]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[7]  Christopher X. Wong,et al.  Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  M. Josephson,et al.  Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. , 2003, The American journal of cardiology.

[9]  G. Lip,et al.  Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry , 2013, PloS one.

[10]  Prashanthan Sanders,et al.  The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia. , 2012, Archives of internal medicine.

[11]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[12]  Christopher X. Wong,et al.  Factors associated with the epidemic of hospitalizations due to atrial fibrillation. , 2012, The American journal of cardiology.

[13]  Vikas Singh,et al.  Contemporary Trends of Hospitalization for Atrial Fibrillation in the United States, 2000 Through 2010: Implications for Healthcare Planning , 2014, Circulation.

[14]  Christopher X. Wong,et al.  Aortic Stiffness in Lone Atrial Fibrillation: A Novel Risk Factor for Arrhythmia Recurrence , 2013, PloS one.

[15]  H. Crijns,et al.  Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. , 2012, European heart journal.

[16]  Matthew Reynolds,et al.  Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[17]  Á. Alonso,et al.  A rising tide: the global epidemic of atrial fibrillation. , 2014, Circulation.